Skip to main navigation Skip to search Skip to main content

Electrical impedance tomography-guided positive end-expiratory pressure and mortality of patients with the acute respiratory distress syndrome: the EITVent randomized clinical trial

  • Chi-Ards Net (Chinese ARDS Research Network)
  • , Xueyan Yuan
  • , Ming Zhong
  • , Zhe Li
  • , Ling Sang
  • , Xiaobo Huang
  • , Rui Zhang
  • , Hui Chen
  • , Yuan Gao
  • , Yuxian Wang
  • , Zhimin Lin
  • , Sen Lu
  • , Fang Yang
  • , Tao Chen
  • , Lanqi Guo
  • , Jianfeng Xie
  • , Zhanqi Zhao
  • , Yingzi Huang
  • , Yi Yang
  • , Tommaso Mauri
  • Haibo Qiu, Ling Liu
  • Southeast University, Nanjing
  • Zhongshan Hospital
  • Fudan University
  • Shanghai Jiao Tong University
  • First Affiliated Hospital of Guangzhou Medical University
  • Guangzhou Medical College
  • University of Electronic Science and Technology of China
  • University of York
  • Chinese Academy of Medical Sciences
  • Furtwangen University
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

RATIONALE: Physiological studies showed benefits for bedside setting of personalized positive end-expiratory pressure (PEEP) by electrical impedance tomography (EIT), balancing lung overdistension and collapse. OBJECTIVES: To evaluate whether EIT-guided PEEP improves the clinical outcomes of patients with acute respiratory distress syndrome (ARDS) compared to the lower PEEP/FiO2 table strategy. 

METHODS: This randomized trial enrolled adult patients with moderate to severe ARDS across five sites in China from February 2022 to June 2023. Participants were randomly assigned to EIT-guided PEEP (collapse-overdistension crossing point value by decremental PEEP trial) or the classical lower PEEP/FiO2 table. The primary outcome was 28-day mortality. 

MEASUREMENTS AND MAIN RESULTS: The trial was terminated early for futility, based on a pre-planned interim analysis. A total of 190 patients were included and completed follow-up. PEEP levels didn't differ between groups during the first 7 days (difference in marginal means 0.2 [SE 0.1]; P = .187). At 28 days, mortality was 52 patients (55.9%) in the EIT-guided PEEP group and 51 patients (52.6%) in the lower PEEP/FiO2 table group (hazard ratio [HR] 0.96 [95% CI, 0.65-1.41]; P = .821). Ventilator-free days and other secondary clinical and safety outcomes did not differ, either. However, EIT-guided PEEP assigned higher PEEP and decreased mortality in patients with higher lung recruitability, as assessed by the recruitment-inflation ratio method (16 [35.6%] of 45 patients vs 27 [60.0%] of 45 patients; HR 0.49 [95% CI, 0.26-0.91]; P = .024). 

CONCLUSIONS: In patients with moderate to severe ARDS, EIT-guided PEEP did not significantly reduce 28-day mortality compared with the lower PEEP/FiO2 table strategy. Due to early termination, the study may have been underpowered to detect a clinically important difference. 

Original languageEnglish
Pages (from-to)440-451
Number of pages12
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume212
Issue number3
Early online date23 Jan 2026
DOIs
Publication statusPublished - 31 Mar 2026

Keywords

  • acute respiratory distress syndrome
  • electrical impedance tomography
  • lower PEEP/FiO2 table
  • positive end-expiratory pressure

Fingerprint

Dive into the research topics of 'Electrical impedance tomography-guided positive end-expiratory pressure and mortality of patients with the acute respiratory distress syndrome: the EITVent randomized clinical trial'. Together they form a unique fingerprint.

Cite this